Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Scientists find signs of extreme aging and youth in the same 117-year-old | ScienceDaily (opens in a new tab)

sciencedaily.com · 2026-09-11

Short answerEvidenceSource

Short answer

Mostly not supported

Mostly not supported.

One claim goes further than the study. 3 other points were not covered by the paper.

  • 1 supported
  • 1 overstated
  • 3 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly not supported

One claim overstates the study. One of five checks out. Three claims the study doesn't address.

  • 1 supported
  • 1 overstated
  • 3 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5OverstatedThe story says Branyas's lack of serious disease let researchers distinguish aging from disease in a person of such extreme age, making it a rare view of aging itself.View evidenceHide evidence

Why this verdict

The profile supports an interpretive attempt to separate signatures of extreme chronological age from features associated with preserved health. But the story's framing that the case let researchers clearly distinguish aging from disease, and especially the quoted 'first study' framing, outruns the abstract-level evidence, which is single-subject, cross-sectional, correlational, and explicitly requires larger longitudinal validation.

1

Study evidence

The abstract attributes telomere attrition, abnormal B cell population, and clonal hematopoiesis to the individual’s record-breaking advanced chronological age.

“the record-breaking advanced age is manifested by telomere attrition, abnormal B cell population, and clonal hematopoiesis”
Claim 2 of 5Not coveredResearchers published the final peer-reviewed results from an unusually detailed study of Maria Branyas, who lived beyond 117 years, using multi-omic analysis across genomic, proteomic, epigenomic, metabolomic and microbiomic layers.View evidenceHide evidence

As statedbeyond 117 years; most comprehensive biological investigation yet conducted on a supercentenarian

Why this verdict

The abstract-level profile supports a high-throughput multi-omics study of the world's oldest living supercentenarian, spanning genome, transcriptome, metabolome, proteome, microbiome, and epigenome. However, the supplied abstract profile does not verify the person's name, the exact age claim of beyond 117, the 'final peer-reviewed results' framing, or the magnitude claim that this was the most comprehensive biological investigation yet conducted on a supercentenarian.

1

Study evidence

The supercentenarian exhibits telomere attrition, an abnormal B cell population, and clonal hematopoiesis, interpreted as manifestations of extreme chronological age.

“we have performed a high-throughput multiomics study of the world's oldest living person, interrogating her genome, transcriptome, metabolome, proteome, microbiome, and epigenome”
Claim 3 of 5Not coveredThe article says the study found short telomeres, an immune system with pro-inflammatory characteristics, and an aged population of B lymphocytes.View evidenceHide evidence

Why this verdict

The abstract-level profile supports telomere attrition and an abnormal B-cell population as age-related findings. It does not, at this depth, verify the more specific story wording that the immune system had pro-inflammatory characteristics or that the B-cell population was specifically 'aged' rather than abnormal.

1

Study evidence

The supercentenarian exhibits telomere attrition, an abnormal B cell population, and clonal hematopoiesis, interpreted as manifestations of extreme chronological age.

“we have performed a high-throughput multiomics study of the world's oldest living person, interrogating her genome, transcriptome, metabolome, proteome, microbiome, and epigenome”
2

Study evidence

The abstract attributes telomere attrition, abnormal B cell population, and clonal hematopoiesis to the individual’s record-breaking advanced chronological age.

“the record-breaking advanced age is manifested by telomere attrition, abnormal B cell population, and clonal hematopoiesis”
Claim 4 of 5Not coveredThe article says Branyas also had low inflammatory levels, a gut microbiome dominated by beneficial bifidobacteria, protective genetic characteristics, and an epigenetic biological age younger than her chronological age.View evidenceHide evidence

As statedbiological age younger than chronological age

Why this verdict

The abstract-level profile supports low inflammation, rare/protective genetic variants, a younger epigenome, and a rejuvenated bacteriome as features associated with preserved health. It does not verify the more specific claim that the gut microbiome was dominated by beneficial bifidobacteria.

1

Study evidence

The supercentenarian exhibits telomere attrition, an abnormal B cell population, and clonal hematopoiesis, interpreted as manifestations of extreme chronological age.

“we have performed a high-throughput multiomics study of the world's oldest living person, interrogating her genome, transcriptome, metabolome, proteome, microbiome, and epigenome”
2

Study evidence

Compared with larger matched cohorts, the subject showed features interpreted as manifestations of extreme chronological age: telomere attrition, an abnormal B cell population, and evidence of clonal hematopoiesis.

“comparing the results with larger matched cohorts”
Claim 5 of 5SupportedThe researchers said Branyas showed a 'fascinating duality' with simultaneous signs of extreme aging and healthy longevity.View evidenceHide evidence

Why this verdict

The paper profile supports the story's 'duality' framing: the abstract maps some features to extreme chronological age and others to preserved health or absence of typical age-associated diseases.

1

Study evidence

The abstract attributes telomere attrition, abnormal B cell population, and clonal hematopoiesis to the individual’s record-breaking advanced chronological age.

“the record-breaking advanced age is manifested by telomere attrition, abnormal B cell population, and clonal hematopoiesis”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Comparisons with larger matched cohorts were used to contextualize the individual's multi-omics findings.

    The story presentation summarizes findings as coming from multi-omic analysis but does not report the matched-cohort comparative component that the abstract profile identifies as important for interpretation.

    From comparative matched-cohort analysis

  • Extreme-age signatures included telomere attrition, abnormal B-cell population, and clonal hematopoiesis.

    The story reflects telomere attrition and B-cell abnormalities, but it omits clonal hematopoiesis, which the paper profile lists as one of the age-manifestation findings.

    From single-participant multi-omics case profiling; other

  • Single-participant case design limits generalizability to broader populations.

    The story caveats mention uncertainty about connecting traits to lifestyle and about future anti-aging interventions, but the supplied caveats do not acknowledge the major limitation that the evidence comes from one extreme individual.

    From single-participant multi-omics case profiling; comparative matched-cohort analysis; other

  • Cross-sectional observational profiling cannot establish temporal sequence or causality between molecular features and health outcomes.

    The story includes some caution about not tying traits directly to behaviors, but it does not clearly state the broader paper limitation that the molecular features are correlational and cannot establish causality or timing.

    From single-participant multi-omics case profiling; comparative matched-cohort analysis; other

  • The abstract lacks quantitative effect sizes, detailed comparator information, and statistical-method detail; validation in larger longitudinal cohorts is required.

    These interpretation-changing evidentiary limits are present in the paper profile but are not reflected in the story presentation's caveats.

    From single-participant multi-omics case profiling; comparative matched-cohort analysis; other

3 things the story did carry across
  • Single-participant high-throughput multi-omics case profile of the world's oldest living supercentenarian across genome, epigenome, transcriptome/immune landscape, proteome, metabolome, and microbiome.
  • Interpretive mapping of findings into two groups: manifestations of extreme chronological age versus features associated with preserved health or absence of typical age-associated disease.
  • Preserved-health-associated features included rare European-population genetic variants, low inflammation, a rejuvenated bacteriome, and a younger epigenome.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoCreate a multi-omics “blueprint” of the world’s oldest living person (a supercentenarian) by profiling genome, epigenome, transcriptome/immune cell landscape, proteome/metabolome, and microbiome, and contextualizing these findings against matched comparison cohorts.single-participant multi-omics case profilingExpand

In plain English

A single-participant, high-throughput multi-omics case profile of the world’s oldest living person (supercentenarian) integrating genome, epigenome, transcriptome/immune cell landscape, proteome, metabolome, and microbiome data and contextualizing these molecular features against matched comparison cohorts to identify features linked to extreme chronological age versus preserved health.

Key findings

  • The supercentenarian exhibits telomere attrition, an abnormal B cell population, and clonal hematopoiesis, interpreted as manifestations of extreme chronological age.
  • Despite advanced age, the individual lacks typical age-associated diseases and shows molecular features associated with preserved health: rare European-population genetic variants, low inflammation levels, a rejuvenated bacteriome, and a younger-appearing epigenome.
“we have performed a high-throughput multiomics study of the world's oldest living person, interrogating her genome, transcriptome, metabolome, proteome, microbiome, and epigenome”
What this piece can’t prove
  • Single-participant case study limits generalizability to broader populations.
  • Cross-sectional profiling cannot determine temporal sequence or causality between molecular features and health outcomes.
  • Authors note need for larger cohorts and longitudinal prospective studies to validate and extrapolate findings.

1 further detail could not be confirmed from the summary.

2secondary dataCreate a multi-omics “blueprint” of the world’s oldest living person (a supercentenarian) by profiling genome, epigenome, transcriptome/immune cell landscape, proteome/metabolome, and microbiome, and contextualizing these findings against matched comparison cohorts.comparative matched-cohort analysisExpand

In plain English

The paper reports a comparative analytical component in which multi-omics measurements from the world's oldest living person (a supercentenarian) were contextualized against larger matched cohorts to distinguish signatures attributable to extreme chronological age from those associated with preserved health. The abstract states that comparisons to matched cohorts support interpretation that some molecular features (telomere attrition, abnormal B cell populations, clonal hematopoiesis) reflect extreme age, whereas other features (rare population-specific genetic variants, low inflammation, a rejuvenated bacteriome, and a younger epigenome) are associated with absence of typical age-related disease.

Key findings

  • Compared with larger matched cohorts, the subject showed features interpreted as manifestations of extreme chronological age: telomere attrition, an abnormal B cell population, and evidence of clonal hematopoiesis.
  • Compared with larger matched cohorts, the subject exhibited features associated with absence of typical age-related disease: presence of rare European-population genetic variants, low systemic inflammation, a rejuvenated gut bacteriome, and an epigenetic profile considered younger than expected for chronological age.
“comparing the results with larger matched cohorts”
What this piece can’t prove
  • Single-index subject: comparisons hinge on a single individual's measurements and therefore have limited generalizability.
  • Abstract omits essential comparator details (cohort sizes, demographic matching variables, inclusion/exclusion criteria) and specific statistical methods or effect estimates.
  • Authors acknowledge need for larger cohorts and longitudinal prospective studies to validate and generalize findings.

1 further detail could not be confirmed from the summary.

3otherLink specific biological signatures in this individual to (a) extreme chronological age (e.g., telomere attrition, B cell abnormalities, clonal hematopoiesis) versus (b) relative absence of common age-associated diseases (e.g., low inflammation, ‘rejuvenated’ microbiome, younger epigenome, rare protective variants).Expand

In plain English

The abstract reports an interpretive mapping of multiomics measurements in the world's oldest living person onto two conceptual axes: (a) features attributed as manifestations of extreme chronological age (telomere attrition, abnormal B cell populations, and clonal hematopoiesis) and (b) features associated with an absence of common age-associated diseases (rare European-population genetic variants, low inflammation, a 'rejuvenated' bacteriome, and a younger epigenome). These attributions are presented after profiling multiple omics layers and comparing the individual to larger matched cohorts; the authors state that broader extrapolation will require larger, longitudinal studies.

Key findings

  • The abstract attributes telomere attrition, abnormal B cell population, and clonal hematopoiesis to the individual’s record-breaking advanced chronological age.
  • The abstract associates rare European-population genetic variants, low inflammation levels, a 'rejuvenated' bacteriome, and a younger epigenome with the relative absence of common age-associated diseases in this individual.
“the record-breaking advanced age is manifested by telomere attrition, abnormal B cell population, and clonal hematopoiesis”
What this piece can’t prove
  • Single-individual study: attributions derive from one extreme-age subject, limiting generalizability.
  • Interpretive synthesis: the mapping of observed features to 'extreme age' versus 'healthy aging' is interpretive and does not establish causation.
  • Authors note need for larger cohorts and longitudinal prospective studies to validate and extrapolate these biomarker attributions.

1 further detail could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 37 candidate papers

Candidate

A ATUAÇÃO DO FARMACÊUTICO NA FARMÁCIA COMERCIAL

IV SEMINÁRIO INTERNACIONAL AGENDA 2030 DA ONU: EMPREENDEDORISMO E INOVAÇÃO PARA O DESENVOLVIMENTO SUSTENTÁVEL · 2025 · Crossref

Source (opens in a new tab)

And 31 more candidates considered.